Tuberous Sclerosis Complex―Associated Angiomyolipomas: Focus on mTOR InhibitionBUDDE, Klemens; GAEDEKE, Jens.American journal of kidney diseases. 2012, Vol 59, Num 2, pp 276-283, issn 0272-6386, 8 p.Article

Target Enzyme Activity as a Biomarker for ImmunosuppressionGLANDER, Petra; BUDDE, Klemens.Therapeutic drug monitoring. 2010, Vol 32, Num 3, pp 257-260, issn 0163-4356, 4 p.Conference Paper

Belatacept utilization recommendations: an expert positionGRINYO, Josep M; BUDDE, Klemens; CITTERIO, Franco et al.Expert opinion on drug safety. 2013, Vol 12, Num 1, pp 111-122, issn 1474-0338, 12 p.Article

Novel mediators of FTY720 in human lymphocytesBÖHLER, Torsten; BUDDE, Klemens; NEUMAYER, Hans-H et al.Transplantation. 2005, Vol 79, Num 4, pp 492-495, issn 0041-1337, 4 p.Article

FTY720 mediates apoptosis-independent lymphopenia in human renal allograft recipients: Different effects on CD62L⁺ and CCR5⁺ t lymphocytesBOHLER, Torsten; WAISER, Johannes; SCHÜTZ, Manuela et al.Transplantation. 2004, Vol 77, Num 9, pp 1424-1432, issn 0041-1337, 9 p.Article

Impact of St John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patientsMAI, Ingrid; STÖRMER, Elke; BAUER, Steffen et al.Nephrology, dialysis, transplantation (Print). 2003, Vol 18, Num 4, pp 819-822, issn 0931-0509, 4 p.Article

A Cardiovascular Risk Calculator for Renal Transplant RecipientsSOVERI, Nga; HOLME, Ingar; HOLDAAS, Hallvard et al.Transplantation. 2012, Vol 94, Num 1, pp 57-62, issn 0041-1337, 6 p.Article

Pregnancy on intensified hemodialysis: Fetal surveillance and perinatal outcomeBAMBERG, Christian; DIEKMANN, Fritz; HAASE, Michael et al.Fetal diagnosis and therapy. 2007, Vol 22, Num 4, pp 289-293, issn 1015-3837, 5 p.Article

The pharmacokinetics of pioglitazone in patients with impaired renal functionBUDDE, Klemens; NEUMAYER, Hans-Hellmut; FRITSCHE, Lutz et al.British journal of clinical pharmacology. 2003, Vol 55, Num 4, pp 368-374, issn 0306-5251, 7 p.Article

Differential effects of single dose FTY720 on CD62L+ B-cells in stable renal allograft recipientsBÖHLER, Torsten; SCHÜTZ, Manuela; BUDDE, Klemens et al.International immunopharmacology. 2007, Vol 7, Num 1, pp 88-95, issn 1567-5769, 8 p.Article

Successful treatment of nephrogenic fibrosing dermopathy in a kidney transplant recipient with photodynamic therapySCHMOOK, Tobias; BUDDE, Klemens; ULRICH, Claas et al.Nephrology, dialysis, transplantation (Print). 2005, Vol 20, Num 1, pp 220-222, issn 0931-0509, 3 p.Article

Glomerular activin A overexpression is linked to fibrosis in anti-Thy1 glomerulonephritisGAEDEKE, Jens; BOEHLER, Torsten; BUDDE, Klemens et al.Nephrology, dialysis, transplantation (Print). 2005, Vol 20, Num 2, pp 319-328, issn 0931-0509, 10 p.Article

MDR1 haplotypes do not affect the steady-state pharmacokinetics of cyclosporine in renal transplant patientsMAI, Ingrid; STÖRMER, Elke; GOLDAMMER, Mark et al.Journal of clinical pharmacology. 2003, Vol 43, Num 10, pp 1101-1107, issn 0091-2700, 7 p.Article

The immunosuppressive potential of misoprostol: efficacy and variabilityWAISER, Johannes; BÖHLER, Torsten; STOLL, Juliane et al.Clinical immunology (Orlando, Fla. Print). 2003, Vol 109, Num 3, pp 288-294, issn 1521-6616, 7 p.Article

Steroid-and calcineurin inhibitor free immunosuppression in kidney transplantation : state of the art and future developmentsGIESSING, Markus; FULLER, Tom Florian; TUELLMANN, Max et al.World journal of urology (Print). 2007, Vol 25, Num 3, pp 325-332, issn 0724-4983, 8 p.Article

Reporting of rejection after renal transplantation in large immunosuppressive trials : Biopsy-proven, clinical, presumed, or treated rejection?FLEINER, Franca; FRITSCHE, Lutz; GLANDER, Petra et al.Transplantation. 2006, Vol 81, Num 5, pp 655-659, issn 0041-1337, 5 p.Article

FTY720 exerts differential effects on CD4⁺ and CD8⁺T-lymphocyte subpopulations expressing chemokine and adhesion receptorsBÖHLER, Torsten; WAISER, Johannes; SCHUETZ, Manuela et al.Nephrology, dialysis, transplantation (Print). 2004, Vol 19, Num 3, pp 702-713, issn 0931-0509, 12 p.Article

Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trialBUDDE, Klemens; BECKER, Thomas; ARNS, Wolfgang et al.Lancet (British edition). 2011, Vol 377, Num 9768, pp 837-847, issn 0140-6736, 11 p.Article

Safety and Efficacy of Intensified Versus Standard Dosing Regimens of Enteric-Coated Mycophenolate Sodium in De Novo Renal Transplant PatientsSOMMERER, Claudia; GLANDER, Petra; SCHMIDT, Jan et al.Transplantation. 2011, Vol 91, Num 7, pp 779-785, issn 0041-1337, 7 p.Article

Effects of the new immunosuppressive agent AEB071 on human immune cellsMATZ, Mareen; WEBER, Ulrike; MASHREGHI, Mir-Farzin et al.Nephrology, dialysis, transplantation (Print). 2010, Vol 25, Num 7, pp 2159-2167, issn 0931-0509, 9 p.Article

Profibrotic cytokines and lymphocyte proliferation in stable renal allograft recipients treated with or without cyclosporine AWAISER, Johannes; SCHNEIDER, Michael; ELJAZYFER, Sara et al.Clinical immunology (Orlando, Fla. Print). 2006, Vol 119, Num 1, pp 59-66, issn 1521-6616, 8 p.Article

The value of C₂ monitoring in stable renal allograft recipients on maintenance immunosuppressionEINECKE, Gunilla; MAI, Ingrid; FRITSCHE, Lutz et al.Nephrology, dialysis, transplantation (Print). 2004, Vol 19, Num 1, pp 215-222, issn 0931-0509, 8 p.Article

Tolerability and steady-state pharmacokinetics of everolimus in maintenance renal transplant patientsBUDDE, Klemens; NEUMAYER, Hans-Hellmut; LEHNE, Gustav et al.Nephrology, dialysis, transplantation (Print). 2004, Vol 19, Num 10, pp 2606-2614, issn 0931-0509, 9 p.Article

Weight gain in long-term survivors of kidney or liver transplantation—Another paradigm of sarcopenic obesity?SCHÜTZ, Tatjana; HUDJETZ, Heike; ROSKE, Anne-Eve et al.Nutrition (Burbank, Los Angeles County, Calif.). 2012, Vol 28, Num 4, pp 378-383, issn 0899-9007, 6 p.Article

Limited Sampling Strategies Drawn Within 3 Hours Postdose Poorly Predict Mycophenolic Acid Area-Under-the-Curve After Enteric-Coated Mycophenolate SodiumDE WINTER, Brenda C. M; VAN GELDER, Teun; MATHOT, Ron A. A et al.Therapeutic drug monitoring. 2009, Vol 31, Num 5, pp 585-591, issn 0163-4356, 7 p.Article